PARVOVIRUS B 19 - ANVISA Registration 10338930160

Access comprehensive regulatory information for PARVOVIRUS B 19 in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10338930160 and manufactured by manufacturer not specified. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Jan 19, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASORIN ITALIA S.P.A., DIASORIN MOLECULAR LLC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10338930160
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930160
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Parvovírus B19 IgG
Risk Class III

Registration Details

10338930160

25351634704201404

93741726000166

Company Information

Dates and Status

Jan 19, 2015

19/01/2035

09/18/2025 19:00:01

Parvovírus B19 IgG
Risk Class III

Registration Details

10338930160

25351634704201404

93741726000166

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jan 19, 2015

19/01/2035

09/18/2025 19:00:01